Hematology/Oncology News

HER2-positive breast cancer has become one of the most treatable breast cancer types among patients of all ages, including those aged 40 years and younger.

Despite the incidence of endometrial cancer diagnosis increasing annually, several promising approaches for treatment and diagnosis of endometrial cancer have been approved or are in development.

A cross-sectional study yielded new insights into the extent of financial hardship among cancer survivors, as well as which individuals may be at greatest risk.

Adjuvant radiotherapy reduced risk for local recurrence for a decade among women with early breast cancer who underwent breast-conserving surgery, results of a randomized phase 3 trial showed.

The AI revolution already has transformed delivery of cancer care.

Physicians can use social media to combat medical misinformation that spreads through it, according to a speaker at the Osteopathic Medical Education Conference.

CHICAGO — In this Healio video exclusive, Jacqueline Winkelmann, MD, FAAP, discusses the value of the Women in Medicine Summit and shares career and life advice.

A novel therapeutic approach may improve the persistence and functionality of chimeric antigen receptor T cells, helping to prevent relapse.

When Danielle Mitchell told an acquaintance about her mission to better represent Black women in the clinical workforce, the woman responded with a personal story.

Datopotamab deruxtecan failed to extend OS vs. chemotherapy for adults with advanced breast cancer, according to the agent’s manufacturer.